BTAI
Bioxcel Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
3.55 / 10Overall Score
NeturalInvestment Rating
3.55 / 10Overall Score
NeturalInvestment Rating
Is BTAI a Good Buy Right Now?
- Based on a composite score of 3.55/10, we rate BTAI as a Netural. Our analysis breaks down into 2.97/10 for Fundamentals, 2.30/10 for Technicals, and 4.46/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of BTAI?
Is BTAI undervalued or overvalued?
Is money flowing into or out of BTAI?
Is BTAI a Good Buy Right Now?
- Based on a composite score of 3.55/10, we rate BTAI as a Netural. Our analysis breaks down into 2.97/10 for Fundamentals, 2.30/10 for Technicals, and 4.46/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is BTAI undervalued or overvalued?
Technical Analysis of BTAI?
Is money flowing into or out of BTAI?
